2-amino-1-hydroxyethyl-8-hydroxyquinolin-2 (1h) -one salts derivatives having both beta2 adrenergic receptor agonist activity and m3 muscarinic receptor antagonist activity

摘要

Patent Summary: "Derived from 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2 (1h) -one salts having both beta2 adrenergic receptor agonist activity and m3 muscarinic receptor antagonist activity". The present invention relates to crystalline addition salts of (i) 8-hydroxyquinolin-2 (1h) -one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvate thereof.